Becton Dickinson

May 09, 2019

Becton Dickinson Fiscal Q2 Revenues Down 1 Percent

The company reaffirmed its full fiscal year 2019 comparable, currency-neutral revenue guidance, and updated its adjusted diluted EPS guidance.

May 03, 2019

In Brief This Week: Danaher, HTG Molecular, Bruker, and More

Apr 10, 2019

European Initiative Aims to Reshape Use of Diagnostics in Treating Infectious Diseases

Premium

VALUE-Dx involves six IVD companies and is being heralded by participants as an opportunity for competitors to work together to improve test adoption.

Apr 05, 2019

Siemens Healthineers, Beckman Coulter, Becton Dickinson, Others Receive FDA Clearances in March

Beckman Coulter got regulatory clearance for three in vitro diagnostic products, including its DxH 520 hematology analyzer for low-volume clinical labs.

Mar 26, 2019

BD Gets CE-IVD Mark for Clinical Flow Cytometry Sample Prep System

The system is used to automate sample preparation steps for assays that are run on BD's FACSLyric clinical flow cytometer.

Feb 05, 2019

BD Fiscal Q1 Revenues Grow 35 Percent

The company reported growth across all three of its business segments and reaffirmed its full-year guidance.

Jan 25, 2019

In Brief This Week: Illumina, Novacyt, Lustgarten Foundation, and More

Jan 17, 2019

BD Preliminary Fiscal Q1 Revenues Up 35 Percent on Continued Bard Boost

The firm also reaffirmed its previous guidance of 10 percent growth for fiscal 2019.

Jan 15, 2019

BioMérieux, DiaSorin, GenMark, and Others Receive FDA Clearances in December

GenMark got clearance for an assay to detect fungal pathogens from blood cultures of patients with suspected bloodstream infections, and it received clearance for a bacterial assay.

Jan 10, 2019

JP Morgan Healthcare, Day 3: Quidel, Oxford Immunotec, Luminex, GenMark, Bio-Techne, and More

Among the updates provided Wednesday, Quidel's CEO noted the firm's growing presence in point-of-care markets, while PerkinElmer discussed plans for its Vanadis test.

Menu

Becton Dickinson